Cost-effectiveness of moderate-to-severe psoriasis treatment

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.2, 2006-02, pp. : 157-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Topical Calcipotriol versus Short- Contact Dithranol: In the Treatment of Mild to Moderate Plaque Psoriasis

By Ashcroft D.M.

PharmacoEconomics, Vol. 18, Iss. 5, 2000-11 ,pp. : 469-476

Adis International

Access to resources Recommend Favorite

Treatment failure rate, costs high in moderate-to-severe psoriasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 473, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Treatment failure rate, costs high in moderate-to-severe psoriasis

Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Emerging drugs for moderate-to-severe psoriasis

By Magliocco Melissa A

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 35-52

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab useful for moderate-to-severe plaque psoriasis

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite